Literature DB >> 15551287

Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.

Sa Wang1, Barbara A Degar, Arthur Zieske, Nelofar Q Shafi, Michal G Rose.   

Abstract

We describe a 75-year-old man with neutropenia in whom bone marrow aspirate and biopsy demonstrated hemophagocytosis associated with myelodysplasia (MDS). Therapy with granulocyte-colony stimulating factor (G-CSF) and granulocyte-monocyte-colony stimulating factor (GM-CSF) caused splenomegaly and severe thrombocytopenia, which recurred upon rechallenge. We propose that myeloid growth factors may be detrimental in patients with MDS-associated hemophagocytosis. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551287     DOI: 10.1002/ajh.20202

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  Hemophagocytic lymphohistiocytosis associated with myelodysplastic syndromes.

Authors:  Takahiro Tsuji; Hiroshi Yamasaki; Nobuyuki Arima; Hiroyuki Tsuda
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

2.  Hemophagocytic lymphohistiocytosis: critical reappraisal of a potentially under-recognized condition.

Authors:  Somanath Padhi; Renu G' Boy Varghese; Anita Ramdas; Manjiri Dilip Phansalkar; RajLaxmi Sarangi
Journal:  Front Med       Date:  2013-10-14       Impact factor: 4.592

3.  Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.

Authors:  Thomas N Burn; Lehn Weaver; Julia E Rood; Niansheng Chu; Aaron Bodansky; Portia A Kreiger; Edward M Behrens
Journal:  Arthritis Rheumatol       Date:  2019-12-15       Impact factor: 10.995

4.  Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropenia.

Authors:  Omer Nuri Pamuk; Gülsüm Emel Pamuk; Ufuk Usta; Necati Cakir
Journal:  Clin Rheumatol       Date:  2006-03-21       Impact factor: 2.980

5.  Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.

Authors:  Karen Delavigne; Emilie Bérard; Sarah Bertoli; Jill Corre; Eliane Duchayne; Cécile Demur; Véronique Mansat-De Mas; Cécile Borel; Muriel Picard; Muriel Alvarez; Audrey Sarry; Françoise Huguet; Christian Récher
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

Review 6.  Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Authors:  Haneen Shalabi; Juliane Gust; Agne Taraseviciute; Pamela L Wolters; Allison B Leahy; Carlos Sandi; Theodore W Laetsch; Lori Wiener; Rebecca A Gardner; Veronique Nussenblatt; Joshua A Hill; Kevin J Curran; Timothy S Olson; Colleen Annesley; Hao-Wei Wang; Javed Khan; Marcelo C Pasquini; Christine N Duncan; Stephan A Grupp; Michael A Pulsipher; Nirali N Shah
Journal:  Nat Rev Clin Oncol       Date:  2021-01-25       Impact factor: 66.675

Review 7.  Hemophagocytic lymphohistiocytosis (HLH): a review of literature.

Authors:  Rohtesh S Mehta; Roy E Smith
Journal:  Med Oncol       Date:  2013-10-09       Impact factor: 3.738

Review 8.  Viral infections associated with haemophagocytic syndrome.

Authors:  Nadine Rouphael Maakaroun; Abeer Moanna; Jesse T Jacob; Helmut Albrecht
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

Review 9.  Infections associated with haemophagocytic syndrome.

Authors:  Nadine G Rouphael; Naasha J Talati; Camille Vaughan; Kelly Cunningham; Roger Moreira; Carolyn Gould
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

10.  Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.

Authors:  Laura J Janke; Denise M Imai; Heather Tillman; Rosalinda Doty; Mark J Hoenerhoff; Jiajie J Xu; Zachary T Freeman; Portia Allen; Natalie Wall Fowlkes; Ilaria Iacobucci; Kirsten Dickerson; Charles G Mullighan; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2020-11-19       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.